-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
-
Summary
-
Sunshine Biopharma Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from 2012 to 2023.
- Sunshine Biopharma Inc. Nonoperating Income (Expense) for the quarter ending September 30, 2024 was $124K, a 26.7% decline year-over-year.
- Sunshine Biopharma Inc. Nonoperating Income (Expense) for the twelve months ending September 30, 2024 was $776K, a 24.1% increase year-over-year.
- Sunshine Biopharma Inc. annual Nonoperating Income (Expense) for 2023 was $674K, a 37.7% increase from 2022.
- Sunshine Biopharma Inc. annual Nonoperating Income (Expense) for 2022 was $490K.
- Sunshine Biopharma Inc. annual Nonoperating Income (Expense) for 2021 was -$10M, a 353% decline from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Growth (%)